A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

NCT04925141 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myelogenous Leukemia - Chronic Phase

Interventions

DRUG: Dasatinib Tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.